Individual clinical outcome of patients who received a Treg dose ≥ 30 × 105/kg
UPN* . | Time to neutrophil recovery . | Time to acute GVHD . | Maximum grade of acute GVHD . | Time to relapse . | Time to last follow-up . | Status at last follow-up . |
---|---|---|---|---|---|---|
Cyclosporine A + mycophenolate mofetil | ||||||
4837 | 34 | – | 0 | – | 52 | Dead |
4855 | 7 | 39 | 2 | 400 | 430 | Dead |
4872 | 6 | 20 | 1 | – | 727 | Alive |
4908 | 7 | 33 | 2 | – | 371 | Alive |
4915 | 20 | – | 0 | – | 388 | Alive |
4930 | GF | 39 | 4 | – | 157 | Dead |
4936 | 6 | – | 0 | 21 | 202 | Dead |
4963 | 13 | 29 | 2 | – | 365 | Alive |
4975 | 8 | 41 | 2 | – | 375 | Alive |
4654 | 7 | – | 0 | 97 | 365 | Alive |
5039 | 3 | 37 | 2 | – | 372 | Alive |
5002 | 36 | 66 | 3 | – | 375 | Alive |
Sirolimus + mycophenolate mofetil | ||||||
5083 | 9 | – | 0 | – | 384 | Alive |
5087 | 16 | 86 | 3 | 103 | 359 | Alive |
5117 | 7 | – | 0 | – | 368 | Alive |
5121 | 38 | – | 0 | – | 365 | Alive |
5125 | 41 | – | 0 | – | 373 | Alive |
5151 | GF | – | NA | – | 151 | Dead |
UPN* . | Time to neutrophil recovery . | Time to acute GVHD . | Maximum grade of acute GVHD . | Time to relapse . | Time to last follow-up . | Status at last follow-up . |
---|---|---|---|---|---|---|
Cyclosporine A + mycophenolate mofetil | ||||||
4837 | 34 | – | 0 | – | 52 | Dead |
4855 | 7 | 39 | 2 | 400 | 430 | Dead |
4872 | 6 | 20 | 1 | – | 727 | Alive |
4908 | 7 | 33 | 2 | – | 371 | Alive |
4915 | 20 | – | 0 | – | 388 | Alive |
4930 | GF | 39 | 4 | – | 157 | Dead |
4936 | 6 | – | 0 | 21 | 202 | Dead |
4963 | 13 | 29 | 2 | – | 365 | Alive |
4975 | 8 | 41 | 2 | – | 375 | Alive |
4654 | 7 | – | 0 | 97 | 365 | Alive |
5039 | 3 | 37 | 2 | – | 372 | Alive |
5002 | 36 | 66 | 3 | – | 375 | Alive |
Sirolimus + mycophenolate mofetil | ||||||
5083 | 9 | – | 0 | – | 384 | Alive |
5087 | 16 | 86 | 3 | 103 | 359 | Alive |
5117 | 7 | – | 0 | – | 368 | Alive |
5121 | 38 | – | 0 | – | 365 | Alive |
5125 | 41 | – | 0 | – | 373 | Alive |
5151 | GF | – | NA | – | 151 | Dead |
GF indicates graft failure; GVHD, graft-versus-host disease; Treg, regulatory T cell; and UPN, unique patient number.
The UPN column is listed by the order of patient accrual and treatment in the protocol.